Lenvatinib as a therapy for unresectable hepatocellular carcinoma
Lenvatinib as a therapy for unresectable hepatocellular carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Lenvatinib as a therapy for unresectable hepatocellular carcinoma have?
Lenvatinib as a therapy for unresectable hepatocellular carcinoma has 39 citations in the OpenAlex counts ScholarIQ stores.
When was Lenvatinib as a therapy for unresectable hepatocellular carcinoma published?
Lenvatinib as a therapy for unresectable hepatocellular carcinoma has 2018 year in the ScholarIQ index.
What is the open-access status of Lenvatinib as a therapy for unresectable hepatocellular carcinoma?
Lenvatinib as a therapy for unresectable hepatocellular carcinoma has closed oa status in the ScholarIQ index.
What is the DOI of Lenvatinib as a therapy for unresectable hepatocellular carcinoma?
The DOI for Lenvatinib as a therapy for unresectable hepatocellular carcinoma is on the source record.
What is the PMID of Lenvatinib as a therapy for unresectable hepatocellular carcinoma?
The PMID for Lenvatinib as a therapy for unresectable hepatocellular carcinoma is on the source record.
What is the OpenAlex record for Lenvatinib as a therapy for unresectable hepatocellular carcinoma?
The OpenAlex for Lenvatinib as a therapy for unresectable hepatocellular carcinoma is on the source record.